Outset Medical Inc is a medical technology company focused on transforming dialysis care through innovative solutions
The company has developed a portable, computerized dialysis machine designed to enhance the efficiency and ease of patient treatment for chronic kidney disease. By simplifying the dialysis process, Outset Medical aims to improve patient outcomes and expand access to life-saving therapies, all while supporting healthcare providers in delivering high-quality, cost-effective care. Their technology seeks to modernize traditional dialysis practices and make treatment more patient-centered.
SAN JOSE, Calif., Feb. 03, 2025 (GLOBE NEWSWIRE) -- Outset Medical, Inc. (Nasdaq: OM) (“Outset”), a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis, today announced that it will release financial results for the fourth quarter and full-year 2024 after the close of trading on Wednesday, February 19, 2025.
SAN JOSE, Calif., Jan. 08, 2025 (GLOBE NEWSWIRE) -- Outset Medical, Inc. (Nasdaq: OM) (“Outset”), a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis, today announced that Chair & CEO Leslie Trigg will present at the 43rd annual J.P. Morgan Healthcare conference on Wednesday, January 15, 2025, at 8:15 a.m. Pacific time.
It's Motley Fool Money's annual Thanksgiving financial meal. We're serving up humble pie, talking about the topics we're skipping this year at the dinner table, and answering questions you've sent our way.
NEW YORK, Dec. 03, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Outset Medical, Inc. (NASDAQOM) on behalf of long-term stockholders following a class action complaint that was filed against Outset Medical on August 29, 2024 with a Class Period from August 1, 2022 to August 7, 2024. Our investigation concerns whether the board of directors of Outset Medical have breached their fiduciary duties to the company.
SAN JOSE, Calif., Nov. 15, 2024 (GLOBE NEWSWIRE) -- Outset Medical, Inc. (Nasdaq: OM) (“Outset”), a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis, today announced that members of management will present at the 2024 Stifel Healthcare conference on Tuesday, November 19, 2024, at 10:20 a.m. Eastern time.
SAN JOSE, Calif., Oct. 23, 2024 (GLOBE NEWSWIRE) -- Outset Medical, Inc. (Nasdaq: OM) (“Outset”), a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis, today announced that it will release financial results for the third quarter of 2024 after the close of trading on Wednesday, November 6, 2024.
NEW YORK, Oct. 22, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of GitLab Inc. (NASDAQGTLB), Outset Medical, Inc. NASDAQ: OMNASDAQOM)(NASDAQ: ZINASDAQZI, and Super Micro Computer, Inc. (NASDAQ: SMCINASDAQ). Stockholders have until the deadlines below to petition the court to serve as lead plaintiff. Additional information about each case can be found at the link provided.
Berman Tabacco announces that it has filed a securities class action complaint in the United States District Court for the Northern District of California against Outset Medical, Inc. (“Outset” or the “Company”) (NASDAQOM) and certain current and former officers. This new securities class action is related to a pending case against Outset in the Northern District of California captioned Porcelli v. Outset Medical, Inc., et al., Case No. 24-CV-6124. The new class action complaint, however, alleges a longer class period and is brought on behalf of purchasers of Outset securities between September 15, 2020, and August 7, 2024, inclusive (the “Expanded Class Period”). The newly filed case is captioned Plymouth County Retirement Association v. Outset Medical, Inc., et al., Case No. 5:24-CV-07267, and alleges violations of Sections 10(b) and 20(a) of the Securities Exchange Act of 1934.
NEW YORK, Oct. 15, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of Outset Medical, Inc. (NASDAQOM), Starbucks Corporation NASDAQ:SBUXNASDAQSBUX)(NYSE: DAVANYSEDAVA, and Sage Therapeutics, Inc. (NASDAQ: SAGENASDAQ). Stockholders have until the deadlines below to petition the court to serve as lead plaintiff. Additional information about each case can be found at the link provided.
NEW YORK, Oct. 09, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of Outset Medical, Inc. (NASDAQOM), Starbucks Corporation NASDAQ:SBUXNASDAQSBUX)(NYSE: DAVANYSEDAVA, and Sage Therapeutics, Inc. (NASDAQ: SAGENASDAQ). Stockholders have until the deadlines below to petition the court to serve as lead plaintiff. Additional information about each case can be found at the link provided.
NEW YORK, Oct. 05, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of Outset Medical, Inc. (NASDAQOM), Starbucks Corporation NASDAQ:SBUXNASDAQSBUX)(NYSE: DAVANYSEDAVA, and Sage Therapeutics, Inc. (NASDAQ: SAGENASDAQ). Stockholders have until the deadlines below to petition the court to serve as lead plaintiff. Additional information about each case can be found at the link provided.
SAN DIEGO, Oct. 04, 2024 (GLOBE NEWSWIRE) -- Robbins LLP reminds investors that a shareholder filed a class action on behalf of all persons and entities that purchased or otherwise acquired Outset Medical, Inc. (NASDAQOM) securities between August 1, 2022 and August 7, 2024. Outset Medical is a medical technology company. Its primary products are the Tablo series devices used in dialysis care, including the Tablo Hemodialysis System and the TabloCart.
NEW YORK, Oct. 01, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of Outset Medical, Inc. (NASDAQOM), Starbucks Corporation NASDAQ:SBUXNASDAQSBUX)(NYSE: DAVANYSEDAVA, and Sage Therapeutics, Inc. (NASDAQ: SAGENASDAQ). Stockholders have until the deadlines below to petition the court to serve as lead plaintiff. Additional information about each case can be found at the link provided.
The law firm of Kirby McInerney LLP announces that a class action lawsuit has been filed in the U.S. District Court for the Northern District of California on behalf of those who acquired Outset Medical, Inc. (“Outset” or the “Company”) (NASDAQOM) securities during the period of August 22, 2022 through August 7, 2024 inclusive (“the Class Period”). Investors have until October 28, 2024 to apply to the Court to be appointed as lead plaintiff in the lawsuit.
NEW YORK, Sept. 26, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of GitLab Inc. (NASDAQGTLB), Outset Medical, Inc. NASDAQ: OMNASDAQOM)(NASDAQ: ZINASDAQZI, and Super Micro Computer, Inc. (NASDAQ: SMCINASDAQ). Stockholders have until the deadlines below to petition the court to serve as lead plaintiff. Additional information about each case can be found at the link provided.
NEW YORK, Sept. 22, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of Sage Therapeutics, Inc. (NASDAQSAGE), Outset Medical, Inc. NASDAQ: OMNASDAQOM)(NASDAQ: ALLRNASDAQALLR, and Super Micro Computer, Inc. (NASDAQ: SMCINASDAQ). Stockholders have until the deadlines below to petition the court to serve as lead plaintiff. Additional information about each case can be found at the link provided.
SAN DIEGO, Sept. 17, 2024 (GLOBE NEWSWIRE) -- Robbins LLP reminds investors that a shareholder filed a class action on behalf of all persons and entities that purchased or otherwise acquired Outset Medical, Inc. (NASDAQOM) securities between August 1, 2022 and August 7, 2024. Outset Medical is a medical technology company. Its primary products are the Tablo series devices used in dialysis care, including the Tablo Hemodialysis System and the TabloCart.
NEW YORK, Sept. 14, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of Starbucks Corporation (NASDAQSBUX), Sage Therapeutics, Inc. NASDAQ: SAGENASDAQSAGE)(NASDAQ: OMNASDAQOM, and Super Micro Computer, Inc. (NASDAQ: SMCINASDAQ). Stockholders have until the deadlines below to petition the court to serve as lead plaintiff. Additional information about each case can be found at the link provided.
Attorney Advertising--Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Outset Medical, Inc. (“Outset Medical” or “the Company”) (NASDAQOM) and certain of its officers.
NEW YORK, Sept. 10, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of Starbucks Corporation (NASDAQSBUX), Sage Therapeutics, Inc. NASDAQ: SAGENASDAQSAGE)(NASDAQ: OMNASDAQOM, and Super Micro Computer, Inc. (NASDAQ: SMCINASDAQ). Stockholders have until the deadlines below to petition the court to serve as lead plaintiff. Additional information about each case can be found at the link provided.
